Nuvation Bio (NYSE:NUVB) Receives Outperform Rating from Wedbush
Wedbush reaffirmed their outperform rating on shares of Nuvation Bio (NYSE:NUVB – Free Report) in a research report sent to investors on Wednesday, Benzinga reports. They currently have a $5.00 price target on the stock. Other analysts also recently issued research reports about the stock. HC Wainwright reissued a buy rating and set a $8.00 […]
More Stories
SPDR ICE Preferred Securities ETF (NYSEARCA:PSK) Sets New 52-Week Low – Here’s What Happened
SPDR ICE Preferred Securities ETF (NYSEARCA:PSK – Get Free Report)’s share price reached a new 52-week low during trading on...
VR Resources (CVE:VRR) Shares Down 16.7% – What’s Next?
VR Resources Ltd. (CVE:VRR – Get Free Report)’s stock price was down 16.7% on Friday . The stock traded as...
Global Medical REIT (NYSE:GMRE) Hits New 52-Week Low – Here’s What Happened
Global Medical REIT Inc. (NYSE:GMRE – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on...
B&M European Value Retail (OTCMKTS:BMRRY) Hits New 1-Year Low – Here’s What Happened
Shares of B&M European Value Retail S.A. (OTCMKTS:BMRRY – Get Free Report) reached a new 52-week low during mid-day trading...
PageGroup (OTCMKTS:MPGPF) Sets New 12-Month Low – Here’s What Happened
PageGroup plc (OTCMKTS:MPGPF – Get Free Report) hit a new 52-week low during mid-day trading on Friday . The stock...
Basf (OTCMKTS:BASFY) Reaches New 12-Month Low – Here’s What Happened
Basf Se (OTCMKTS:BASFY – Get Free Report)’s share price reached a new 52-week low during trading on Friday . The...